NuGen Medical Devices Inc. (TSXV: NGMD)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
NuGen Medical Devices Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 0.76 | 0.33 | 0.15 | 0.14 | 0.05 | - | Upgrade
|
| Revenue Growth (YoY) | 312.97% | 117.52% | 10.69% | 191.04% | - | - | Upgrade
|
| Cost of Revenue | 0.4 | 0.17 | 0.05 | 0.05 | 0.01 | - | Upgrade
|
| Gross Profit | 0.36 | 0.16 | 0.1 | 0.09 | 0.03 | - | Upgrade
|
| Selling, General & Admin | 6.2 | 7.52 | 4.24 | 5.26 | 2.26 | 1.88 | Upgrade
|
| Operating Expenses | 6.84 | 8.21 | 4.89 | 5.88 | 2.62 | 1.93 | Upgrade
|
| Operating Income | -6.49 | -8.05 | -4.79 | -5.79 | -2.59 | -1.93 | Upgrade
|
| Interest Expense | -1.27 | -1.24 | -1.01 | -1.21 | -0.42 | -0.11 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.02 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.16 | -0.11 | -0.1 | 0.3 | -0.16 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.87 | 0.02 | 0.06 | -1.11 | -0.23 | - | Upgrade
|
| EBT Excluding Unusual Items | -8.78 | -9.38 | -5.84 | -7.81 | -3.38 | -2.05 | Upgrade
|
| Asset Writedown | - | - | - | -0.16 | -0.02 | - | Upgrade
|
| Other Unusual Items | 0.51 | 0.05 | 0.27 | 0.87 | -0.26 | 0.07 | Upgrade
|
| Pretax Income | -8.27 | -9.33 | -5.57 | -7.1 | -3.66 | -1.98 | Upgrade
|
| Income Tax Expense | 0.04 | 0.03 | 0 | 0 | 0.01 | - | Upgrade
|
| Net Income | -8.31 | -9.36 | -5.58 | -7.11 | -3.67 | -1.98 | Upgrade
|
| Net Income to Common | -8.31 | -9.36 | -5.58 | -7.11 | -3.67 | -1.98 | Upgrade
|
| Shares Outstanding (Basic) | 209 | 168 | 90 | 69 | 54 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 209 | 168 | 90 | 69 | 54 | 24 | Upgrade
|
| Shares Change (YoY) | 50.14% | 86.08% | 31.20% | 26.95% | 128.66% | 20.39% | Upgrade
|
| EPS (Basic) | -0.04 | -0.06 | -0.06 | -0.10 | -0.07 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.06 | -0.06 | -0.10 | -0.07 | -0.08 | Upgrade
|
| Free Cash Flow | -3.17 | -6.72 | -2.13 | -4.1 | -1.4 | -1.81 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.02 | -0.06 | -0.03 | -0.08 | Upgrade
|
| Gross Margin | 47.01% | 49.74% | 65.09% | 67.00% | 72.70% | - | Upgrade
|
| Operating Margin | -850.30% | -2428.48% | -3146.56% | -4207.91% | -5475.96% | - | Upgrade
|
| Profit Margin | -1089.45% | -2825.02% | -3661.07% | -5163.23% | -7760.66% | - | Upgrade
|
| Free Cash Flow Margin | -415.82% | -2026.89% | -1399.36% | -2977.84% | -2958.59% | - | Upgrade
|
| EBITDA | -5.95 | -7.44 | -4.22 | -5.17 | -2.22 | -1.92 | Upgrade
|
| D&A For EBITDA | 0.54 | 0.61 | 0.58 | 0.63 | 0.37 | 0 | Upgrade
|
| EBIT | -6.49 | -8.05 | -4.79 | -5.79 | -2.59 | -1.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.